Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

Fluoropyrimidines (FLs) have been widely used for more than 60 years against a range of solid tumors and still remains the cornerstone for the treatment of colorectal, gastric, and breast cancer. Here, we performed an economic analysis to estimate the cost of DPYD-guided toxicity management and the...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	American journal of human genetics Ročník 104; číslo 6; s. 1158
Hlavní autoři:	Fragoulakis, Vasileios, Roncato, Rossana, Fratte, Chiara Dalle, Ecca, Fabrizio, Bartsakoulia, Marina, Innocenti, Federico, Toffoli, Giuseppe, Cecchin, Erika, Patrinos, George P, Mitropoulou, Christina
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 06.06.2019
Témata:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Cost-Benefit Analysis Dihydrouracil Dehydrogenase (NADP) - genetics Dihydrouracil Dehydrogenase (NADP) - metabolism Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - etiology Drug-Related Side Effects and Adverse Reactions - pathology Female Follow-Up Studies Genetic Testing - methods Humans Male Middle Aged Neoplasms - drug therapy Neoplasms - economics Neoplasms - genetics Neoplasms - pathology Polymorphism, Single Nucleotide Prognosis Pyrimidines - adverse effects Retrospective Studies Survival Rate antimetabolite fluoropyrimidines cost-effectiveness economic evaluation DPYD genotyping FL
ISSN:	1537-6605, 1537-6605
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!